These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31686375)

  • 1. Nanodelivery of phytobioactive compounds for treating aging-associated disorders.
    Lushchak O; Strilbytska O; Koliada A; Zayachkivska A; Burdyliuk N; Yurkevych I; Storey KB; Vaiserman A
    Geroscience; 2020 Feb; 42(1):117-139. PubMed ID: 31686375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanodelivery of Natural Antioxidants: An Anti-aging Perspective.
    Vaiserman A; Koliada A; Zayachkivska A; Lushchak O
    Front Bioeng Biotechnol; 2019; 7():447. PubMed ID: 31998711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
    Wang S; Su R; Nie S; Sun M; Zhang J; Wu D; Moustaid-Moussa N
    J Nutr Biochem; 2014 Apr; 25(4):363-76. PubMed ID: 24406273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.
    Ganesan P; Arulselvan P; Choi DK
    Int J Nanomedicine; 2017; 12():1097-1111. PubMed ID: 28223801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models.
    Ganesan P; Ko HM; Kim IS; Choi DK
    Int J Nanomedicine; 2015; 10():6757-72. PubMed ID: 26604750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Nanotechnological Strategies for Skin Anti-aging.
    Pozos-Nonato S; Domínguez-Delgado CL; Campos-Santander KA; Benavides AA; Pacheco-Ortin SM; Higuera-Piedrahita RI; Resendiz-González G; Molina-Trinidad EM
    Curr Pharm Biotechnol; 2023; 24(11):1397-1419. PubMed ID: 36567280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nanotechnology on the oral delivery of phyto-bioactive compounds.
    Nsairat H; Lafi Z; Al-Sulaibi M; Gharaibeh L; Alshaer W
    Food Chem; 2023 Oct; 424():136438. PubMed ID: 37244187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.
    Dudhipala N; Veerabrahma K
    Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol nanoformulations: challenges and opportunities.
    Summerlin N; Soo E; Thakur S; Qu Z; Jambhrunkar S; Popat A
    Int J Pharm; 2015 Feb; 479(2):282-90. PubMed ID: 25572692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol-loaded nanomedicines for cancer applications.
    Annaji M; Poudel I; Boddu SHS; Arnold RD; Tiwari AK; Babu RJ
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1353. PubMed ID: 33655717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
    Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
    Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacting the Remedial Potential of Nano Delivery-Based Flavonoids for Breast Cancer Treatment.
    Sindhu RK; Verma R; Salgotra T; Rahman MH; Shah M; Akter R; Murad W; Mubin S; Bibi P; Qusti S; Alshammari EM; Batiha GE; Tomczyk M; Al-Kuraishy HM
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of quercetin: problems and promises.
    Cai X; Fang Z; Dou J; Yu A; Zhai G
    Curr Med Chem; 2013; 20(20):2572-82. PubMed ID: 23514412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress on therapeutic potential of quercetin].
    Feng YL; Li H; Liu J; Ruan Z; Zhai GY
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5185-5193. PubMed ID: 34738418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol.
    Salman Ul Islam ; Ahmed MB; Mazhar Ul-Islam ; Shehzad A; Lee YS
    Curr Pharm Des; 2019; 25(34):3620-3632. PubMed ID: 31605574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases.
    Khot KB; Gopan G; Bandiwadekar A; Jose J
    Ageing Res Rev; 2023 Jan; 83():101806. PubMed ID: 36427765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations.
    Yakubu J; Pandey AV
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
    Leone F; Cavalli R
    Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.